Skip to main content
logo
Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.340
-0.040 (-2.90%)
At close: Jan 28, 2026, 4:00 PM EST
1.340
0.00 (0.00%)
After-hours: Jan 28, 2026, 4:00 PM EST

Edesa Biotech Revenue

In the fiscal year ending September 30, 2025, Edesa Biotech had annual revenue of $783.89K with 12.26% growth. Edesa Biotech had revenue of $247.15K in the quarter ending September 30, 2025, with 564.11% growth.

Revenue (ttm)
$783.89K
Revenue Growth
+12.26%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
11.25M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2025783.89K85.62K12.26%
Sep 30, 2024698.28K117.24K20.18%
Sep 30, 2023581.04K-199.22K-25.53%
Sep 30, 2022780.26K-9.56M-92.45%
Sep 30, 202110.34M10.01M3,045.01%
Sep 30, 2020328.80K116.95K55.21%
Sep 30, 2018211.85K-16.44K-7.20%
Sep 30, 2017228.29K-1.04M-82.05%
Sep 30, 20161.27M513.00K67.62%
Sep 30, 2015758.69K386.56K103.88%
Aug 31, 2014372.13K-173.34K-31.78%
Aug 31, 2013545.47K259.42K90.69%
Aug 31, 2012286.05K-411.13K-58.97%
Aug 31, 2011697.19K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

EDSA News

More News